COVID 19 & MS This new Brazilian study (11,560 people with MS) evaluated the incidence, clinical outcome, and impact of COVID-19. The results: the incidence of COVID-19 in participants with MS was not different from those observed for the general population. The majority (87% ) were mild cases. Most of them were on MS disease-modifying […]